Published online Jan 15, 2024. doi: 10.4251/wjgo.v16.i1.79
Peer-review started: September 27, 2023
First decision: October 24, 2023
Revised: November 2, 2023
Accepted: November 29, 2023
Article in press: November 29, 2023
Published online: January 15, 2024
Processing time: 105 Days and 17.6 Hours
Radical resection is the standard treatment for gastric cancer, but it can lead to cognitive dysfunction and negative emotions. The choice of anesthesia can impact these outcomes. The mechanisms behind postoperative dysfunctions are not fully understood but are related to stress response, hypoxemia, and neuronal damage. Previous research has shown conflicting results regarding the effects of propofol and sevoflurane anesthesia on cognitive function and emotions.
Understanding the effects of different anesthesia agents on cognitive function and emotions is crucial for improving postoperative outcomes and patient well-being. The selection of appropriate anesthesia agents can potentially reduce complications and improve recovery for patients undergoing radical resection for gastric cancer.
The aim of this study was to compare the effects of propofol and sevoflurane anesthesia on cognitive function, anxiety, and depression in patients undergoing radical resection of gastric cancer. The study also aimed to determine which anesthesia agent is more effective in reducing cognitive dysfunction and negative emotions in these patients.
This study included 80 patients undergoing radical resection of gastric cancer. Cognitive function was assessed using the Loewenstein occupational therapy cognitive assessment evaluation scale, while anxiety and depression were evaluated using the self-rating anxiety scale and self-rating depression scale, respectively. The patients were divided into a propofol group and a sevoflurane group based on the anesthesia agent used. Statistical analyses were performed to compare the outcomes between the two groups.
The study found that both propofol and sevoflurane anesthesia significantly decreased cognitive function after treatment. However, the propofol group had a lower cognitive function score at T4 compared to the sevoflurane group. Additionally, the sevoflurane group had lower scores for anxiety and depression compared to the propofol group. These results suggest that sevoflurane anesthesia may have a greater capacity to alleviate cognitive dysfunction and negative emotions in gastric cancer patients.
In conclusion, both propofol and sevoflurane can be used as maintenance anesthesia during radical resection of gastric cancer. Propofol anesthesia has minimal influence on pulmonary function, promoting postoperative recovery. Sevoflurane minimally affects cognitive function and negative emotions, leading to an improved postoperative mental state. The choice of anesthesia agents should be based on individual patient considerations and specific circumstances.
Further research with a larger sample size is needed to verify the results of the present study and to explore the effects of anesthesia agents in different age groups. Future studies should also investigate the underlying mechanisms behind the effects of anesthesia on cognitive function and emotions. Additionally, exploring other potential factors that can impact postoperative outcomes and recovery in gastric cancer patients would be valuable.